Depression Clinical Trial
— COCOVOfficial title:
Care Outcomes for Chiropractic Outpatient Veterans Aim 3-pilot Trial
Verified date | May 2020 |
Source | Palmer College of Chiropractic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objectives of this pilot trial are to evaluate the feasibility, safety and
acceptability of an integrative care pathway that includes chiropractic care, for the
coordinated care for Veterans Administration (VA) patients with chronic low back pain (cLBP),
with an emphasis on those with mental health comorbidity, in preparation for the conduct of
an appropriately powered multi-site randomized controlled trial (RCT). The secondary
objectives are to collect study outcomes at the baseline visit (BV) and at weeks 3, 5, 7, and
10 to: 1) assess the success of collecting outcomes; 2) determine the outcome measures to use
in a future RCT; and 3) determine preliminary intervention effect sizes and variability to
aid in sample size determination for a future RCT. The investigators hypothesize that
chiropractic care offers relief for pain and mental health symptoms through the direct
effects of treatment-focused CMT, as well as through the indirect, non-specific effects of
the team-based relationship with the clinician.
This pilot study is a single-arm trial. All participants will be asked to complete study
outcomes which include the Roland Morris Disability Questionnaire (RMDQ), LBP intensity and
interference as measured by the Defense and Veterans Pain Rating Scale (DVPRS), as well as
the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item Scale
(GAD-7), Alcohol Use Disorders Identification Test (AUDIT), Post-traumatic Stress Disorder
Checklist-Civilian Version (PLC-C), self-care behaviors, Keele Start Back Screening Tool
(STarT Back), Healing Encounters and Attitudes Lists (HEAL), Expectations for Complementary
and Integrative Treatments Questionnaire (EXPECT), and Pain Intensity, Enjoyment of Life,
General Activity Assessment Tool (PEG) questionnaires, and the Pain Assessment Screening Tool
and Outcomes Registry (PASTOR) assessment, which includes measures of pain, disability,
mental health, quality of life enjoyment and satisfaction. All participants will receive up
to 10 weeks of chiropractic care and will complete outcome assessments at weeks 3, 5, 7, and
10 of the study.
Status | Completed |
Enrollment | 40 |
Est. completion date | November 5, 2018 |
Est. primary completion date | November 5, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Veterans age 18 years or older - Self-reported chronic LBP - Ability to sign informed consent form Exclusion Criteria: - Use of chiropractic care within the past 90 days - Impaired cognitive ability - Not a candidate for chiropractic care - Not able to attend chiropractic appointments - Identified as at risk for suicide |
Country | Name | City | State |
---|---|---|---|
United States | VA Community Based Outpatient Clinic | Coralville | Iowa |
United States | Palmer Center for Chiropractic Research | Davenport | Iowa |
United States | Iowa City Veterans Affairs Health Care System | Iowa City | Iowa |
United States | The Spine Institute for Quality | Oskaloosa | Iowa |
Lead Sponsor | Collaborator |
---|---|
Palmer College of Chiropractic | National Center for Complementary and Integrative Health (NCCIH), University of Iowa |
United States,
Lisi AJ, Salsbury SA, Hawk C, Vining RD, Wallace RB, Branson R, Long CR, Burgo-Black AL, Goertz CM. Chiropractic Integrated Care Pathway for Low Back Pain in Veterans: Results of a Delphi Consensus Process. J Manipulative Physiol Ther. 2018 Feb;41(2):137- — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration of Study Recruitment | As part of the feasibility assessment, the investigators will monitor the amount of time it takes to complete study recruitment and enrollment, and data collection. The investigators will monitor this through a data capture program. | From date of first participant enrolled to date last participant is enrolled, up to 8 months. | |
Primary | Diversity of Patient Demographics | As part of the recruitment plan, investigators are trying to target female and minority veterans. Historically these groups have been underrepresented in veteran research. The investigators will review EHR data for participant demographics. | Screening through baseline | |
Primary | Number of Participants Engaged in Use of MyHealthEVet | As part of the feasibility assessment, investigators will monitor the number of study participants who enroll in and have at least one communication with MyHealthEVet. MyHealthEVet is an online communication tool designed to partner veterans and the veteran's health care team. It provides information on the veteran's health record and health topics as well as allows messaging communication between veterans and health care providers. Usage reports generated by MyHealthEVet will be analyzed to determine number of study participants engaged. | 10 weeks from Baseline | |
Primary | Acceptability | Acceptability will be assessed by conducting structured, qualitative exit interviews with participants and providers. | At Week 10 of the study | |
Primary | Number of Participants With Reported Adverse Events | Safety for this study will be assessed by the number of adverse events counted and recorded. | 10 weeks from Baseline | |
Primary | Percentage of Participants Who Did Not Attend the Initial Chiropractic Visit, Withdrew, or Are Lost to Follow-up | As part of the feasibility assessment and ability to calculate a sample size for a full scale trial with subgroup analysis, investigators will monitor the percentage of missing data. This will include the percentage of participants who did not attend the initial chiropractic visit and withdraw or are lost to follow-up. | 10 weeks from Baseline | |
Secondary | Roland Morris Low Back Pain Disability Questionnaire (RMDQ) | The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability. (0-24, 0=No Disability, 24=Severe Disability) | Baseline visit and weeks 5 and 10 | |
Secondary | Pain Assessment Screening Tool and Outcomes Registry (PASTOR) | PASTOR is an on-line data collection tool based on the NIH Patient Reported Outcomes Measurement Information System (PROMIS) and adopted by the DoD/VA Pain Management Task Force. Specific measures include the Defense & Veterans Pain Rating Scale (DVPRS), an enhanced 11-item (total range 0-10, 0=no pain, 10=worst pain) numeric rating scale (NRS) that improves on standard pain NRS by including a Faces Rating Scale component; 'traffic light' color-coding system to delineate mild, moderate and severe pain; and word descriptors, paired with 4, 0-10 NRS items to quantify the impact of pain on general activity, sleep, mood, and stress. PASTOR incorporates PROMIS measures for mental health conditions (PTSD, depression, anxiety, anger, and alcohol use), physical and social function, fatigue, and pain interference with daily activities to provide graphical representation of improvements or declines in patient status that are compared to matched US samples on age, race/ethnicity and sex. | Baseline visit and weeks 5 and 10 | |
Secondary | STarT Back Screening Tool | This is a 9-item, validated tool developed by Keele University to be used as a screening tool for patients with low back pain. It stratifies patients based on their prognosis of persistent disabling symptoms and allows practitioners to group patients into 3 categories (low, medium, or high risk of poor outcome). | Baseline visit and week 10 | |
Secondary | Self-Efficacy for Managing Symptoms (SF8a) | Developed by the Patient-Reported Outcomes Measurement Information System (PROMIS), this 8-item, self-reported tool will assess a person's level of confidence to manage/control symptoms, to manage their symptoms in different settings and to keep symptoms from interfering with work, sleep, relationships or recreational activities. Each question usually has five response options ranging in value from 1 to 5. The total raw score for a measure is converted to into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Therefore a person with a T-score of 40 is one SD below the mean. A higher PROMIS T-score represents more of the concept being measured. For example, a T-score of 55 on the PROMIS Self-Efficacy for Managing Symptoms indicates that the respondent has greater self-efficacy for managing their symptoms than the general chronic condition population (half a standard deviation higher). | Baseline visit and week 10 | |
Secondary | Patient Health Questionnaire (PHQ-9) | This instrument is self-reported with nine items and will be used to assess depressive disorder. Total scores range from 0 to 27 with a score of 10-14 considered to be in the moderate range (0-27, 0=No Depression, 27=Severe Depression). It has been tested in primary care settings and has a test-retest reliability of 0.81 to 0.96. | Baseline visit and week 10 | |
Secondary | Generalized Anxiety Disorder-7 (GAD-7) | This instrument is self-reported with seven items and will be used to assess generalized anxiety disorder. At a cut off score of 10 (0-21, 0=No Anxiety Disorder, 21=Severe Anxiety Disorder), it has a sensitivity of 0.89 and specificity of 0.82 for identifying patients with GAD in primary care settings. | Baseline visit and week 10 | |
Secondary | Alcohol Use Disorders Identification Test (AUDIT) | Developed by the World Health Organization (WHO), this 10-item screening questionnaire determines harmful or hazardous consumption of alcohol, correctly classifying 95% of people as having a clinical diagnosis of an alcohol abuse disorder (0-12, 0=No Alcohol Use). | Baseline visit and week 10 | |
Secondary | PTSD Checklist-Civilian (PCL-C) | This 17-item, self-reported instrument will assess PTSD. A total severity score is determined by summing scores from each of 17 items. A change of 5-10 points represents the minimum threshold for determining treatment response; a 10-20 point change represents a clinically significant change in PTSD symptom severity (17-85, 17=Not at all Severe PTSD Symptoms, 85=Extremely Severe PTSD Symptoms). | Baseline visit and week 10 | |
Secondary | Healing Encounters and Attitudes Lists (HEAL) | HEAL is a validated item-bank comprised of 6 domains developed through the Patient Reported Outcomes Measurement Information System (PROMIS) methodology. Investigators will use HEAL to assess nonspecific factors known to influence patient outcomes, including perceptions of the patient-provider connection, healthcare environment, treatment expectancy, spirituality, positive or negative outlook, and attitudes toward complementary and alternative medicine (CAM). A higher T-score represents more of the concept being measured. A T-score of 50 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values are indicative of more positive perception. For example, a T-score of 55 on Patient-Provider Connection indicates that the respondent has a more positive perception toward the patient-provider connection than the general chronic condition population (half a standard deviation higher). | After the initial chiropractic visit | |
Secondary | Pain, Enjoyment, and General Activity (PEG) | The PEG is a 3-item tool to improve assessment and monitoring of chronic pain. The overall PEG-3 score ranges from 0-10 with 10 indicating more pain, more interference with enjoyment of life, and more interference with general activity. Questions assess average pain intensity (P) (AVERAGE pain in past week: 0-10, 0= No Pain, 10=Pain as bad as you can imagine), interference with enjoyment of life (E), and interference with general activity (G) (In past week, how pain interfered with...(0-10, 0=Does not interfere, 10=Completely interferes). | Week 3 and Week 7 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |